(UroToday.com) In a session of the Best Kidney Cancer Poster Presentations at this year’s Society of Urologic Oncology (SUO) virtual annual meeting, Dr. Truong presented an assessment of the prevalence of germline mutations in patients with kidney cancer. It has been accepted that approximately one-in-twenty (5%) of patients with renal cell carcinoma have a hereditary cause, with early age at diagnosis (often <46 years of age) suggested as a criterion for genetic counseling assessment.

X